Shape Therapeutics RNAfix® Editing Platform Achieves >90% Editing in Mouse and Non-Human Primate Brain
May 08, 2024 09:31 ET
|
Shape Therapeutics, Inc.
RNAfix achieves up to 92% editing in the non-human primate brain after AAV-based gRNA delivery RNAfix achieves >95% editing throughout the mouse brain with sustained durability at least 6 months...
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
May 08, 2024 09:00 ET
|
Capricor Therapeutics
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare...
Aerami Therapeutics to Present New Lung Deposition Modeling Data for AER-901, in Development for Pulmonary Hypertension, at the American Thoracic Society 2024 International Conference
May 08, 2024 08:30 ET
|
Aerami Therapeutics Inc
DURHAM, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare...
Blink Charging Launches New Preventative Maintenance Program, Blink Care
May 08, 2024 08:15 ET
|
Blink Charging Co.
Blink Care is an optional maintenance program designed to reduce charger downtime and provide a more seamless charging experience. Bowie, Md., May 08, 2024 (GLOBE NEWSWIRE) -- Blink Charging Co....
Ocean Drive Plastic Surgery's Dr. Alan Durkin to Present Clinical Research on Bellafill at the 12th Chinese Annual Meeting of Minimally-Invasive Aesthetic Medicine
May 08, 2024 08:10 ET
|
Ocean Drive Plastic Surgery
Dr. Alan Durkin of Ocean Drive Plastic Surgery will be joining Suneva Medical as a Key Opinion Leader.
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
May 08, 2024 08:00 ET
|
Nano-X Imaging LTD.
Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an...
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
May 08, 2024 07:30 ET
|
InflaRx N.V.
Virtual R&D event to be held on June 5, 2024 from 12:00 to 2:00 PM EDT – highlighting company plans for INF904 and the opportunity, the role of C5aR in chronic spontaneous urticaria (CSU) and...
Amerigo Announces Q1-2024 Results & Quarterly Dividend
May 08, 2024 07:30 ET
|
Amerigo Resources Ltd
Q1-2024 net income of $4.3 million Quarterly EBITDA1 of $13.6 million – free cash flow to equity1 of $7.3 million Current copper prices substantially above Q1-2024 average Quarterly dividend of...
Sprott Announces First Quarter 2024 Results
May 08, 2024 07:00 ET
|
Sprott Inc.
TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) (“Sprott” or the “Company”) today announced its financial results for the quarter ended March 31, 2024. Management commentary...
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
May 08, 2024 07:00 ET
|
Verve Therapeutics
First patient dosed in Heart-2 Phase 1b clinical trial of VERVE-102 VERVE-201 clinical trial initiation on track for the second half of 2024 Received first milestone payment from Eli Lilly for...